Chitosan-Based Nano-Smart Drug Delivery System in Breast Cancer Therapy
Despite recent advances, cancer remains the primary killer on a global scale. Numerous forms of research have been conducted to discover novel and efficient anticancer medications. The complexity of breast cancer is a major challenge which is coupled with patient-to-patient variations and heterogene...
Main Authors: | Yedi Herdiana, Nasrul Wathoni, Dolih Gozali, Shaharum Shamsuddin, Muchtaridi Muchtaridi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-03-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/15/3/879 |
Similar Items
-
Cytotoxicity Enhancement of α-Mangostin with Folate-Conjugated Chitosan Nanoparticles in MCF-7 Breast Cancer Cells
by: Yedi Herdiana, et al.
Published: (2023-11-01) -
Drug release study of the chitosan-based nanoparticles
by: Yedi Herdiana, et al.
Published: (2022-01-01) -
Scale-up polymeric-based nanoparticles drug delivery systems: Development and challenges
by: Yedi Herdiana, et al.
Published: (2022-07-01) -
α-Mangostin Nanoparticles Cytotoxicity and Cell Death Modalities in Breast Cancer Cell Lines
by: Yedi Herdiana, et al.
Published: (2021-08-01) -
Synthesis of nano-α mangostin based on chitosan and Eudragit S 100
by: Yedi Herdiana, et al.
Published: (2020-01-01)